SEARCH RESULTS

To create your individual collection of articles for download, tick the relevant boxes and click the download button below.
Year
Business Unit
01.2024
In Focus

Vitaquest is answering the people’s quest for new health

In the world of health supplements, it used to be enough to offer just vitamins and minerals. But now, consumers demand nootropics and other new categories of supplements that improve mental health, mental performance and achieve “beauty from within”.  
01.2024
Impact

SHPL is bringing books to children in rural communities

Shanghai Hutchison Pharmaceuticals Ltd is passionate about bringing education to children in rural communities in China. It recently built its 84th library in the country. This repository of learning is in Chengkou, a rural county in the mountains of southwest China and far from the madding crowd. Volunteers from the company were led on this expedition by company president Zhou Junjie.

Zhou made good use of his knowledge of Chinese medicine by conducting a course on traditional Chinese medicines to introduce the concept to children and perhaps inspire them to become healthcare practitioners and to learn more about their Chinese heritage.
01.2024
Impact

Cenovus to support the building of Tawâw Park in Lamont, Alberta

Cenovus is contributing C$100,000 to the building of a children’s park. This will provide an inclusive space for residents and visitors alike to interact and build positive experiences in the town of Lamont, Alberta.

“Tawâw” means “Come in, you’re welcome” or “There is always room for one more” in the language of the local Indigenous people, the Cree. The development is part of Cenovus’ commitment to supporting healthy, safe and resilient communities. There will also be several Indigenous elements, including an orange footbridge to emphasise the importance of a safe space for children – the colour orange reflects that every child matters and represents Orange Shirt Day, a Canadian movement established in response to past injustices visited on Indigenous people and especially their children. Indigenous youth artists will also be invited to decorate the space.  
01.2024
Biz in Brief

Fruquintinib marches on, securing key US approval

Those suffering from metastatic colorectal cancer will soon have another option that could improve their survival rates and extend their lives. HUTCHMED’s partner, global pharmaceutical firm Takeda, has obtained approval from the US Food and Drug Administration to make FRUZAQLA™ (fruquintinib) available on the US market.

The drug has been approved for use in patients as part of a treatment protocol that gives them another chance when other treatments such as chemotherapy have proven ineffective. The development partnership with Takeda is part of a broader global partnership strategy. Achieving this watershed will trigger the delivery of sales royalties as well as a milestone payment as part of a deal that will total up to US$1.13 billion.  
01.2024
Biz in Brief

Unleashing the Power of Vaccines to Fight Cancer!

Scientists are making incredible progress in using vaccines to combat cancer, bringing hope for improved cancer treatments in the future. Researchers at CK Life Sciences are developing vaccines that can slow down the growth and spread of cancer or prevent its recurrence after surgery.

One of their promising vaccines targets two proteins, PD-L1 (programmed death ligand 1) and PRAME (preferentially expressed antigen in melanoma), which are involved in promoting cancer. Normally, the immune system uses T cells to attack cancer cells, but PD-L1 puts the brakes on T cells, preventing them from doing their job. PRAME, on the other hand, promotes cancer cell growth and spread.

CK Life Science’s PD-L1/PRAME dual-targeting vaccine works by stimulating the immune system to produce T cells that can specifically kill cancer cells that have PD-L1 and/or PRAME. It also triggers the production of antibodies that can block PD-L1, allowing the T cells to attack cancer cells more effectively. Additionally, antibodies against PRAME further enhance the killing of cancer cells.

CK Life Sciences presented their innovative research on this vaccine at the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting in San Diego, showcasing its potential for treating liver cancer.  
01.2024
Biz in Brief

ESDlife’s winning ways in 2023

ESDlife’s WeVow lit a fire at the Spark Awards 2023 to win two Gold awards for “Best Promotion Strategy” and “Best Use of Mobile/App”. WeVow is a wedding app that uses AI and data analyses to make life easier for stressed-out couples working on making their big day the best day.

WeVow and a staff engagement app, We+, along with various client projects, have racked up the awards all year long, including the Hong Kong Institute of Marketing Triple Crown Award. The We+ app won Human Resources Online magazine’s Gold for the “Best HR Digital Transformation Strategy”. These are just the highlights of over 15 awards won from those listed plus the Hong Kong Wireless Technology Industry Association, the DigiZ Awards, MOB-Ex Awards, Loyalty and Engagement Awards, Employee Experience Awards and HR Distinction Awards.
01.2024
Biz in Brief

Supplying America’s Heartland: The Duluth Marine Terminal

Lake Superior is the greatest of the Great Lakes, the huge inland freshwater oceans that stretch into the heart of North America. They are a vital waterway, and at their western extremity lies the Duluth Marine Terminal, fuelled and operated by the Cenovus Superior Refinery. This crucial gateway brings goods into the American heartland at the border of two states, Minnesota and Wisconsin.

Freight moved by water is one of the most energy-efficient forms of transport. The terminal also serves as a major refuelling port for ships carrying essential products such as limestone, grain, cement, salt, wind turbines and other cargo. It provides economic support as a transit port for the region and as a local employer is a vital part of the mid-West economy.  

Download

Create a PDF of your selected
stories and download

Copied to clipboard
Downloading PDF. Please wait...